P
Plaban Bhattacharya
Researcher at University of Calcutta
Publications - 11
Citations - 102
Plaban Bhattacharya is an academic researcher from University of Calcutta. The author has contributed to research in topics: Docking (molecular) & Chemistry. The author has an hindex of 5, co-authored 9 publications receiving 78 citations. Previous affiliations of Plaban Bhattacharya include Jadavpur University.
Papers
More filters
Journal ArticleDOI
Pharmacoinformatics study of Piperolactam A from Piper betle root as new lead for non steroidal anti fertility drug development
TL;DR: Endocrine disruptome and later docking guided molecular simulations revealed that Piperolactam A has weaker binding affinity and/or lower probability of binding with nuclear receptors especially hERG and cytochrome P450 and the high Caco-2 permeability suggested more bioavailability hence more therapeutic efficacy of the drug.
Journal ArticleDOI
Evaluation of reversible contraceptive potential of Cordia dichotoma leaves extract
TL;DR: The observations suggested that the developed phyto-pharmaceutical has potential antifertility activity with safety aspects and the reversible contraceptive potential after withdrawal.
Journal ArticleDOI
In Vitro susceptibilities of wild and drug resistant Leishmania donovani amastigotes to piperolactam A loaded hydroxypropyl-β-cyclodextrin nanoparticles.
Plaban Bhattacharya,Plaban Bhattacharya,Subhasish Mondal,Souvik Basak,Pradeep Das,Achintya Saha,Tanmoy Bera +6 more
TL;DR: Piperolactam A (PL), a representative of the inchoate skeleton of aristolactAM chassis might be the source of safe and affordable antileishmanial agents for the cure of deadly Leishmania infections.
Journal ArticleDOI
Fabrication of β-cyclodextrin-mediated single bimolecular inclusion complex: characterization, molecular docking, in-vitro release and bioavailability studies for gefitinib and simvastatin conjugate
Souvik Basak,Sandip Mondal,Suddhasattya Dey,Plaban Bhattacharya,Achintya Saha,Vinay Deep Punetha,Ali Abbas,Nanda Gopal Sahoo +7 more
TL;DR: This manuscript emphasizes simultaneous incorporation of two anticancer drugs, gefitinib and simvastatin, in a single molecule of β‐cyclodextrin for the first time to achieve effective drug delivery.